Madison Square Garden Sports Corp. (MSGS) Stock Price & Analysis
Madison Square Garden Sports Corp. (MSGS) closed at USD 389.48 on Thursday, October 22, 2026, down 5.55% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 412.37; the Oct 22, 2026 session ranged USD 387.84–413.5 on volume of 420,264 shares. Market capitalization is $9.38B, with a 52-week range of USD 207.9–438.93 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MSGS.md
Key facts (MSGS)
- Last four reported quarters (through Jun 30, 2026): revenue $1.15B, net income $7.8M (0.7% margin), free cash flow $61.3M (SEC filings).
- Valuation: P/E 1208.7x (avg 666.5x at the last 2 fiscal year-ends), EV/EBITDA 295.6x, net debt $94.0M.
- Earnings quality: non-operating income -$10.9M vs operating income $28.9M over the last four quarters; P/E excluding non-operating income ≈632.2x (estimate: non-operating income taxed at the company's 35% effective rate).
- 4 of 80 tracked superinvestors hold MSGS (13F, Q2 2026): 0 new, 0 added, 1 reduced, 3 unchanged.
- Analysts: Buy (mean 2.13 on a 1–5 scale) (8 analysts), mean target USD 480.67 (range 415–584).
- Total return with dividends: 1Y +72.2% vs S&P 500 +14.9%; 5Y +124.0% vs S&P 500 +80.3%.
- Next earnings: 2026-10-30, EPS estimate USD -1.15, revenue estimate $40.6M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MSGS)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $821M | $887M | $1.03B | $1.04B | $1.15B | $1.15B |
| Operating income | $86.1M | $85.2M | $146M | $14.8M | $28.9M | $28.9M |
| Net income | $51.1M | $47.8M | $58.8M | -$22.4M | $7.8M | $7.8M |
| EPS (diluted) | $2.10 | $1.89 | $2.44 | -$0.93 | $0.32 | — |
| Free cash flow | $177M | $151M | $90.7M | $88.0M | $61.3M | $61.3M |
| Operating margin | 10.5% | 9.6% | 14.2% | 1.4% | 2.5% | 2.5% |
| Net margin | 6.2% | 5.4% | 5.7% | -2.2% | 0.7% | 0.7% |
| Revenue growth | +97.6% | +8.0% | +15.7% | +1.2% | +11.0% | — |
| Cash + short-term investments | $91.0M | $40.4M | $89.1M | $145M | $165M | — |
| Total debt | $250M | $325M | $305M | $291M | $259M | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (MSGS)
P/E 1208.7x · P/E ex non-operating (est.) ≈632.2x · P/S 8.1x · EV/EBITDA 295.6x · EV/Sales 8.2x · P/FCF 153.1x · FCF yield 0.65% · Earnings yield 0.08% · Dividend yield (paid, TTM) 0.01% · Net debt $94.0M · EV $9.47B
P/E at fiscal year-ends: Jun 2026 1256.0x, Jun 2024 77.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (MSGS)
4 of 80 tracked investors hold MSGS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| John Rogers | Ariel Investments | 2.64% | $265M | Reduced -8.2% |
| Bill Gates | Gates Foundation Trust | 0.69% | $238M | Unchanged |
| Mason Hawkins | Southeastern Asset Management | 0.07% | $1.3M | Unchanged |
| Lindsell Train | 0.04% | $1.1M | Unchanged |
Analysts (MSGS)
Consensus Buy (mean 2.13 on a 1–5 scale), 8 analysts; mean target USD 480.67 (low 415, high 584).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-14 | JP Morgan | Target raised | Overweight | $450 → $485 |
| 2026-08-14 | Susquehanna | Target raised | Positive | $430 → $477 |
| 2026-08-14 | Guggenheim | Target raised | Buy | $522 → $584 |
| 2026-07-23 | Guggenheim | Target raised | Buy | $470 → $522 |
| 2026-07-21 | JP Morgan | Target raised | Overweight | $400 → $450 |
Total return (dividends reinvested) (MSGS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +72.2% | +124.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +72.5% | +17.5% |
| Volatility (annualized) | 29.6% | 25.4% |
| Max drawdown | -10.1% (Feb 2026→Mar 2026) | -31.9% (Nov 2021→Sep 2022) |
MSGS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-1.15 | $-0.87 | +32.0% | $40.6M | 6 |
| Next quarter (ends Dec 2026) | $0.34 | $0.80 | -57.3% | $430.2M | 6 |
| Current fiscal year (ends Jun 2027) | $-1.14 | $-0.60 | +88.4% | $1.08B | 6 |
| Next fiscal year (ends Jun 2028) | $-1.96 | $0.23 | -953.6% | $1.12B | 6 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 389.48 |
|---|---|
| Change | ▼ 5.55% (down) |
| Previous Close | USD 412.37 |
| Open | USD 409.01 |
| Day Range | USD 387.84 – 413.5 |
| 52-Week Range | USD 207.9 – 438.93 |
| Volume | 420,264 shares |
| Market Cap | $9.38B |
| Exchange | NYQ |
Technical Analysis (MSGS)
Nexqual's technical model rates MSGS "NEUTRAL" based on 3 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 41.8 (neutral) |
| vs SMA50 | Below (USD 399.87) |
| MACD | 0.85 (positive) |
Analyst Ratings (MSGS)
Wall Street analysts rate MSGS "Buy" based on 8 analysts, with a mean price target of USD 480.67 (range USD 415–584), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 480.67 |
| High Target | USD 584 |
| Low Target | USD 415 |
| Buy / Hold / Sell | 5 / 3 / 0 |
Earnings (MSGS)
| Next Earnings Date | 2026-10-30 |
|---|---|
| EPS Estimate | USD -1.11 |
| Revenue Estimate | $40.64M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.16 vs est 0.63 ▲ beat |
| 2026-03-31 | USD -0.83 vs est 0.52 ▼ miss |
| 2025-12-31 | USD 0.34 vs est 0.46 ▼ miss |
| 2025-09-30 | USD -0.37 vs est -1.16 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (MSGS)
| Total Revenue | $1.15B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +36.70% |
| Gross Margin | +33.61% |
| Operating Margin | +11.76% |
| Profit Margin | +0.67% |
| Current Ratio | 0.5 |
| Total Cash | $164.51M |
| Total Debt | $1.16B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $61.26M (5.3% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (MSGS)
Nexqual rates Madison Square Garden Sports Corp.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Mixed — Revenue +1.2% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 34%, operating 12% (last 12 months) |
| Balance Sheet | Mixed — $165M cash and investments vs $259M debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $61M (last 4 quarters to Jun 2026, SEC), 5% margin |
| Efficiency | Mixed — No data |
Ownership (MSGS)
| Insider Ownership | +3.50% |
|---|---|
| Institutional Ownership | +102.19% |
| Shares Outstanding | 19.55M |
| Float | 17.11M |
| Short % of Float | +8.81% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (MSGS)
Madison Square Garden Sports Corp. is led by James Lawrence Dolan, Executive Chairman & CEO, per Nexqual as of October 23, 2026 at 09:25 UTC.
| Executive Chairman & CEO | James Lawrence Dolan |
|---|---|
| Executive Vice President | David Granville-Smith |
| Executive VP, CFO & Treasurer | Paul DiCicco |
| Senior Vice President of Investor Relations & Treasury | Ari Danes C.F.A. |
| Vice Chairman | Gregg G. Seibert |
Major Backers & Investors (MSGS)
Notable institutional backers of Madison Square Garden Sports Corp. include Silver Lake Group, LLC, Starlite Capital Inc, T. Rowe Price, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Silver Lake Group, LLC | 9.72% |
| Starlite Capital Inc | 6.16% |
| T. Rowe Price | 5.61% |
| Ariel Investments, LLC | 3.37% |
| Gates Foundation Trust | 3.03% |
| Gamco Investors, Inc ET AL | 3.01% |
| Legg Mason Partners Investment Trust-ClearBridge Growth Fund | 1.69% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 10.74% |
| Vanguard Group | 8.97% |
| State Street | 3% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LLYVK | Liberty Live Holdings, Inc. - S | USD 101.23 | ▲ 0.73% |
| SIRI | SiriusXM Holdings Inc. | USD 27.54 | ▲ 2.15% |
| WMG | Warner Music Group Corp. | USD 31.69 | ▲ 0.8% |
| NWS | News Corporation | USD 33.95 | ▲ 2.01% |
| CNK | Cinemark Holdings Inc Cinemark | USD 39.61 | ▼ 0.78% |
| VSNT | Versant Media Group, Inc. | USD 32.29 | ▲ 3% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt